High Quality Ronidazole CAS 7681-76-7 Powder Fast Shipping Best Price

Ronidazole More Info

Introduction
Ronidazole (CAS No. 7681-76-7) is a synthetic nitroimidazole-class compound with potent antiprotozoal and antibacterial activity, primarily used in veterinary medicine and occasionally in human clinical research. Developed as a derivative of metronidazole, it exhibits enhanced efficacy against a range of protozoa and anaerobic bacteria, particularly those resistant to other nitroimidazoles. Ronidazole is widely recognized for its effectiveness in treating trichomoniasis, giardiasis, and anaerobic infections in companion animals (dogs, cats), livestock, birds, and aquatic species. While not approved for routine human use in most countries, it has been investigated as a second-line therapy for drug-resistant protozoal infections (e.g., Trichomonas vaginalis) and certain anaerobic bacterial diseases. Its unique mechanism of action, broad spectrum of activity, and oral bioavailability make it a critical tool in veterinary practice and translational research.
Mechanism of Action
Core Antimicrobial Mechanisms
Ronidazole exerts its cytotoxic effects through reductive activation in anaerobic or microaerophilic environments, a hallmark of nitroimidazole-class compounds:
Reductive activation: The nitro (-NO₂) group on the ronidazole molecule is reduced by nitroreductase enzymes present in protozoa and anaerobic bacteria. This reduction occurs only in low-oxygen conditions, ensuring selective targeting of pathogens while sparing aerobic host cells.
DNA damage: The reduced metabolites (e.g., nitro radicals, hydroxylamines) interact with the pathogen’s DNA, causing strand breaks, cross-linking, and inhibition of DNA replication and transcription. This irreversible DNA damage leads to pathogen death.
Energy metabolism inhibition: In addition to DNA damage, reduced ronidazole disrupts the pathogen’s energy metabolism by inhibiting pyruvate:ferredoxin oxidoreductase (PFOR), an enzyme critical for ATP production in anaerobic organisms. This dual mechanism enhances its antimicrobial potency.
Protozoa-specific targeting: For protozoa such as Tritrichomonas foetus and Giardia duodenalis, ronidazole accumulates in the parasite’s cytoplasm and mitochondria, targeting both nuclear and mitochondrial DNA—making it effective against both replicating and non-replicating forms.
Pharmacological Effects & Advantages
Key Pharmacological Effects
Antiprotozoal activity: Highly effective against flagellated protozoa, including:
Tritrichomonas foetus (canine trichomoniasis, feline intestinal trichomoniasis)
Trichomonas vaginalis (human and veterinary trichomoniasis)
Giardia duodenalis (giardiasis in humans, dogs, cats, and livestock)
Histomonas meleagridis (histomoniasis in poultry, "blackhead disease")
Spironucleus muris (intestinal protozoosis in rodents and birds)
Antibacterial activity: Active against obligate anaerobic bacteria, such as:
Clostridium spp. (e.g., Clostridium perfringens, Clostridium difficile)
Bacteroides spp. (e.g., Bacteroides fragilis)
Fusobacterium spp.
Anaerobic cocci (e.g., Peptostreptococcus spp.)
Rapid onset of action: Oral administration results in peak plasma concentrations within 1–2 hours in dogs and cats, with pathogen clearance observed within 3–7 days of treatment for most infections.
Tissue penetration: Distributes widely into tissues, including the gastrointestinal tract, reproductive tract, central nervous system (CNS), and abscesses—ensuring efficacy against infections in diverse anatomical sites.
Key Advantages
Broad spectrum: Covers both protozoa and anaerobic bacteria, eliminating the need for combination therapy in mixed infections.
Resistance profile: Effective against many pathogens resistant to metronidazole (a closely related nitroimidazole), due to its higher potency and enhanced ability to penetrate pathogen cells.
Oral bioavailability: Well-absorbed after oral administration in most species (bioavailability >80% in dogs and cats), with flexible dosing via tablets, capsules, or compounded suspensions.
Tolerability: Generally well-tolerated in veterinary species, with minimal adverse effects at therapeutic doses.
Species versatility: Approved or used off-label in dogs, cats, poultry, swine, fish, and exotic animals (e.g., reptiles, birds), making it a versatile tool for mixed-animal practices.
Clinical & Practical Applications
1. Veterinary Clinical Uses
Companion animals (dogs & cats):
Treatment of intestinal trichomoniasis (Tritrichomonas foetus)—the most common indication in cats (causing chronic diarrhea).
Treatment of giardiasis (Giardia duodenalis)—particularly in cases unresponsive to metronidazole.
Management of anaerobic bacterial infections, including periodontal disease, pyoderma, wound infections, uterine infections (pyometra), and gastrointestinal abscesses.
Poultry:
Control of histomoniasis (Histomonas meleagridis) in turkeys and chickens, a highly fatal disease affecting the cecum and liver.
Treatment of trichomoniasis (Trichomonas gallinae) in pigeons and game birds (causing "canker").
Livestock (swine, cattle):
Treatment of giardiasis and anaerobic enteritis in swine.
Adjunctive therapy for bovine genital trichomoniasis (Tritrichomonas foetus), though vaccination is preferred for prevention.
Aquatic species:
Treatment of protozoal infections (e.g., Ichthyophthirius multifiliis, "ich") and anaerobic bacterial diseases in fish (e.g., carp, salmonids).
2. Human Research Applications
Drug-resistant protozoal infections: Investigated as a second-line therapy for metronidazole-resistant Trichomonas vaginalis infections, with clinical trials showing cure rates of 80–90%.
Anaerobic bacterial infections: Used off-label in cases of metronidazole-resistant Clostridium difficile colitis and refractory anaerobic abscesses (e.g., pelvic, hepatic), though data is limited.
Research tool: Used to study nitroimidazole resistance mechanisms in protozoa and bacteria, aiding in the development of next-generation antimicrobial agents.
3. Administration & Dosing Considerations
Routes of administration: Primarily oral (tablets, capsules, compounded suspensions); injectable formulations are available for veterinary use in severe infections.
Dosing guidelines (veterinary):
Dogs/cats: 30–50 mg/kg orally once daily for 5–10 days (trichomoniasis/giardiasis); 10–20 mg/kg orally twice daily for 7–14 days (anaerobic infections).
Poultry: 50–100 mg/kg in feed or water for 3–5 days (histomoniasis/trichomoniasis).
Swine: 20–40 mg/kg orally once daily for 5–7 days (giardiasis/anaerobic enteritis).
Special populations:
Avoid use in pregnant or lactating animals (potential teratogenicity in high doses).
Reduce dose in animals with severe hepatic or renal impairment (metabolized in the liver, excreted in urine/feces).
Not recommended for puppies/kittens younger than 6 weeks old (underdeveloped metabolic pathways).
Handling & Storage
Storage conditions: Store at 25°C (77°F) in a dry, cool place, protected from light and moisture. Keep the container tightly sealed to prevent degradation. Compounded suspensions should be stored at 4°C and used within 14–30 days (per compounding guidelines).
Handling precautions:
For veterinary use only—keep out of reach of children and unauthorized personnel.
Wear disposable gloves when handling tablets or preparing suspensions to avoid skin contact; wash hands thoroughly after use.
Avoid inhalation of dust or powder, as it may cause respiratory irritation.
Pregnant individuals should avoid handling ronidazole, as it may have teratogenic potential in humans.
Disposal: Dispose of unused or expired medication, empty containers, and contaminated materials (e.g., gloves, syringes) in accordance with local veterinary and environmental regulations. Do not discard in household waste or wastewater, as it may contaminate water sources.
Limitations & Research Updates
Limitations
Potential toxicity: High doses or prolonged use may cause neurotoxicity (e.g., ataxia, seizures, tremors) in dogs and cats, particularly in animals with hepatic dysfunction. Gastrointestinal side effects (e.g., vomiting, diarrhea, anorexia) are rare but may occur.
Teratogenicity: Classified as a potential teratogen, limiting use in pregnant animals and humans.
Resistance development: Overuse in veterinary practice has led to emerging resistance in Giardia and Trichomonas populations, highlighting the need for responsible use and resistance monitoring.
Human use restrictions: Not approved for routine human use by major regulatory bodies (e.g., FDA, EMA) due to limited safety data and teratogenic potential.
Narrow spectrum for aerobic bacteria: Ineffective against aerobic or facultative anaerobic bacteria, requiring combination therapy for mixed infections involving both aerobic and anaerobic pathogens.
Research Updates
Resistance management: Ongoing studies are monitoring resistance patterns in veterinary pathogens and developing guidelines for rational use (e.g., limiting use to confirmed infections, avoiding prophylactic use).
Novel formulations: Extended-release oral formulations and water-soluble powders for livestock/poultry are being developed to improve dosing convenience and reduce administration frequency.
Human clinical trials: Phase II/III trials are evaluating ronidazole for the treatment of metronidazole-resistant Trichomonas vaginalis and Clostridium difficile infections, with promising early results.
Combination therapy: Research is exploring combinations of ronidazole with other antiprotozoal agents (e.g., fenbendazole) or antibiotics to enhance efficacy and reduce resistance in mixed infections.
Toxicity reduction: Studies are investigating structural analogs of ronidazole with reduced neurotoxicity and teratogenicity, aiming to expand its safety profile for both veterinary and human use.

Product Image

FAQ

Q1. Can I get a free sample?

We can send you a samll free sample, and you only need to pay for the shipping cost.

Q2. What is the HyperChem payment term?

T/T in advance
LC at sight
DP at sight

Bank transfer

PayPal

Bitcoin...

Q3. What is HyperChem shipment policy?

Our policy is to strive for the quickest shipment time possible.

For ready stock samples, they are usually shipped within 3 working days after payment received.
For non-ready stock, please contact HyperChem sales team to negotiate.

Q4. What is HyperChem shipment term?

By Express  
FedEx  UPS  DHL  EMS                               
Fast: 3-7 days around, high cost, door to door service

By Air                                        
Suitable for more than 50kg 
Fast: 3-7 days, hight cost, port to port, professional broker needed 

By Sea
Suitable for more than 500kg      
Fast: 7-45 days, low cost, port to port, professional broker needed 

We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.

Q5. What HyperChem will provide after shipment?

For sample orders: 
After shipment is done, an timely email including:

1. Track details (Fedex /TNT/DHL/EMS Track number)
2. Packaging photo
3. COA, MSDS, etc
4. Dispatch date & Estimated arriving time
5. Shipping invoice

For commercial orders:
A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.